71
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Early Elevation of Thioredoxin-1 Serum Levels Predicts 28-Day Mortality in Patients with Sepsis

, , , , , , , , , , & show all
Pages 3837-3848 | Published online: 11 Aug 2021

References

  • Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Sepsis and septic shock. Nat Rev Dis Primers. 2016;2:16045.
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
  • Zhou J, Tian H, Du X, et al. Population-based epidemiology of sepsis in a subdistrict of Beijing. Crit Care Med. 2017;45(7):1168–1176. doi:10.1097/CCM.0000000000002414
  • Del Pozo JL. Stewardship in sepsis. Rev Esp Quimioter. 2019;32 Suppl 2(Suppl2):42–46.
  • van Engelen TSR, Wiersinga WJ, Scicluna BP, van der Poll T. Biomarkers in sepsis. Crit Care Clin. 2018;34(1):139–152. doi:10.1016/j.ccc.2017.08.010
  • Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Critical Care. 2010;14(1):R15. doi:10.1186/cc8872
  •  Ulusoy H, Kangalgil M, Küçük AO, et al. Effects of different lipid emulsions on serum adipokines, inflammatory markers and mortality in critically ill patients with sepsis: A prospective observational cohort study. Clin Nutr. 2021;40(7):4569-4578. doi:10.1016/j.clnu.2021.05.037
  • Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426–435. doi:10.1016/S1473-3099(12)70323-7
  • Rowland T, Hilliard H, Barlow G. Procalcitonin: potential role in diagnosis and management of sepsis. Adv Clin Chem. 2015;68:71–86.
  • Samraj RS, Zingarelli B, Wong HR. Role of biomarkers in sepsis care. Shock. 2013;40(5):358–365. doi:10.1097/SHK.0b013e3182a66bd6
  • Charles PE, Gibot S. Predicting outcome in patients with sepsis: new biomarkers for old expectations. Critical Care. 2014;18(1):108. doi:10.1186/cc13723
  • Tamayo E, Fernández A, Almansa R, et al. Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Eur Cytokine Netw. 2011;22(2):82–87. doi:10.1684/ecn.2011.0281
  • Marchant A, Alegre ML, Hakim A, et al. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol. 1995;15(5):266–273. doi:10.1007/BF01540884
  • Gromer S, Urig S, Becker K. The thioredoxin system – from science to clinic. Med Res Rev. 2004;24(1):40–89.
  • Arnér ES, Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem. 2000;267(20):6102–6109. doi:10.1046/j.1432-1327.2000.01701.x
  • Callister ME, Burke-Gaffney A, Quinlan GJ, et al. Extracellular thioredoxin levels are increased in patients with acute lung injury. Thorax. 2006;61(6):521–527. doi:10.1136/thx.2005.053041
  • Bai J, Nakamura H, Kwon YW, et al. Critical roles of thioredoxin in nerve growth factor-mediated signal transduction and neurite outgrowth in PC12 cells. J Neurosci. 2003;23(2):503–509. doi:10.1523/JNEUROSCI.23-02-00503.2003
  • Holmgren A. Antioxidant function of thioredoxin and glutaredoxin systems. Antioxid Redox Signal. 2000;2(4):811–820. doi:10.1089/ars.2000.2.4-811
  • Nakamura H. Thioredoxin as a key molecule in redox signaling. Antioxid Redox Signal. 2004;6(1):15–17. doi:10.1089/152308604771978309
  • Uhle F, Lichtenstern C, Brenner T, Weigand MA. [Pathophysiology of sepsis]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2015;50(2):114–122. [ German]
  • Leaver SK, MacCallum NS, Pingle V, et al. Increased plasma thioredoxin levels in patients with sepsis: positive association with macrophage migtation inhibitory factor. ntensive Care Med. 201036(2);336–341. doi:10.1007/s00134-009-1640-z.
  • Chen G, Li X, Huang M, et al. Thioredoxin-1 increases survival in sepsis by inflammatory response through suppressing endoplasmic reticulum stress. Shock. 2016;46(1):67–74. doi:10.1097/SHK.0000000000000570
  • Yodoi J, Matsuo Y, Tian H, Masutani H, Inamoto T. Anti-inflammatory thioredoxin family proteins for medicare, healthcare and aging care. Nutrients. 2017;9(10):10. doi:10.3390/nu9101081
  • Nasoohi S, Ismael S, Ishrat T. Thioredoxin-interacting protein (TXNIP) in cerebrovascular and neurodegenerative diseases: regulation and implication. Mol Neurobiol. 2018;55(10):7900–7920. doi:10.1007/s12035-018-0917-z
  • Mathys L, Balzarini J. The role of cellular oxidoreductases in viral entry and virus infection-associated oxidative stress: potential therapeutic applications. Expert Opin Ther Targets. 2016;20(1):123–143. doi:10.1517/14728222.2015.1068760
  • Adib-Conquy M, Cavaillon JM. [Host inflammatory and anti-inflammatory response during sepsis]. Pathologie-Biologie. 2012;60(5):306–313. doi:10.1016/j.patbio.2012.03.011. [ Dutch]
  • Salomão R, Ferreira BL, Salomão MC, Santos SS, Azevedo LCP, Brunialti MKC. Sepsis: evolving concepts and challenges. Braz J Med Biol Res. 2019;52(4):e8595. doi:10.1590/1414-431x20198595
  • Nakamura T, Nakamura H, Hoshino T, Ueda S, Wada H, Yodoi J. Redox regulation of lung inflammation by thioredoxin. Antioxid Redox Signal. 2005;7(1–2):60–71. doi:10.1089/ars.2005.7.60
  • Nadeem A, Masood A, Siddiqui N. Oxidant–antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options. Ther Adv Respir Dis. 2008;2(4):215–235. doi:10.1177/1753465808094971
  • Mantzarlis K, Tsolaki V, Zakynthinos E. Role of oxidative stress and mitochondrial dysfunction in sepsis and potential therapies. Oxid Med Cell Longev. 2017;2017:5985209. doi:10.1155/2017/5985209
  • Brigham KL. Oxygen radicals – an important mediator of sepsis and septic shock. Klin Wochenschr. 1991;69(21–23):1004–1008. doi:10.1007/BF01645147
  • Watanabe R, Nakamura H, Masutani H, Yodoi J. Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2. Pharmacol Ther. 2010;127(3):261–270. doi:10.1016/j.pharmthera.2010.04.004
  • Nakamura A, Wada H, Ikejiri M, et al. Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unit. Shock. 2009;31(6):586–591. doi:10.1097/SHK.0b013e31819716fa
  • Kopterides P, Siempos II, Tsangaris I, Tsantes A, Armaganidis A. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2010;38(11):2229–2241. doi:10.1097/CCM.0b013e3181f17bf9
  • Janković B, Veljković D, Pasić S, Rakonjac Z, Jevtić D, Martić J. [C-reactive protein and cytokines in the diagnosis of neonatal sepsis]. Med Pregl. 2006;59(11–12):545–549. doi:10.2298/MPNS0612545J. [ Slovenian]
  • Hofer N, Zacharias E, Müller W, Resch B. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology. 2012;102(1):25–36. doi:10.1159/000336629
  • Ma L, Zhang H, Yin YL, et al. Role of interleukin-6 to differentiate sepsis from non-infectious systemic inflammatory response syndrome. Cytokine. 2016;88:126–135. doi:10.1016/j.cyto.2016.08.033
  • Patel RT, Deen KI, Youngs D, Warwick J, Keighley MR. Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg. 1994;81(9):1306–1308. doi:10.1002/bjs.1800810914
  • Herwanto V, Shetty A, Nalos M, et al. Accuracy of quick sequential organ failure assessment score to predict sepsis mortality in 121 studies including 1,716,017 individuals: a systematic review and meta-analysis. Crit Care Explor. 2019;1(9):e0043. doi:10.1097/CCE.0000000000000043
  • Caraballo C, Jaimes F. Organ dysfunction in sepsis: an ominous trajectory from infection to death. Yale J Biol Med. 2019;92(4):629–640.
  • Vincent JL, Quintairos ESA, Couto L Jr., Taccone FS. The value of blood lactate kinetics in critically ill patients: a systematic review. Critical Care. 2016;20(1):257. doi:10.1186/s13054-016-1403-5
  • Chertoff J, Chisum M, Garcia B, Lascano J. Lactate kinetics in sepsis and septic shock: a review of the literature and rationale for further research. J Intensive Care. 2015;3(1):39. doi:10.1186/s40560-015-0105-4